In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
We recently published an article titled Jim Cramer’s Lightning Rounds: 9 Stocks in Focus. In this article, we are going to ...
Contentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
Hungarys National Centre for Public Health and Pharmacy (NNGYK) is purchasing COVID-19 vaccines for adults and children from ...
BRITS are being urged to stay at home and mask up when venturing outside after a “worrying” surge in norovirus cases. While ...
Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...
Norovirus, also known as the winter vomiting bug, is currently seeing a surge in infections with rates twice as high as previous years. In Wales cases of the virus were up 12% this winter compared ...
Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...
The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...
Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...
Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) gapped down before the market opened on Wednesday after The Goldman Sachs Group downgraded the stock from a buy rating to a neutral rating. The ...